Triggering of t cell proliferation through aim, an activation inducer molecule expressed on activated human lymphocytes

Journal of Experimental Medicine

Volumn 168, Issue 5, 1988, Pages 1621-1637

  Cebrián, Marta ^a   Yagüe, Enriqueta ^a   Rincón, Mercedes ^a   López botet, Miguel ^a   De Landázuri, Manuel O ^a   Sánchez madrid, Francisco ^a  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM IONOPHORE; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; MONOCLONAL ANTIBODY;

ADULT; BIOLOGICAL MODEL; CELL CULTURE; CYTOCHEMISTRY; FEMALE; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MALE; METHODOLOGY; NORMAL HUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; T LYMPHOCYTE;

ANTIBODIES, MONOCLONAL; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CD4-POSITIVE T-LYMPHOCYTES; DISULFIDES; FLOW CYTOMETRY; HUMAN; IN VITRO; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; MOLECULAR WEIGHT; PRECIPITIN TESTS; RECEPTORS, INTERLEUKIN-2; SUPPORT, NON-U.S. GOV'T; T-LYMPHOCYTES; TETRADECANOYLPHORBOL ACETATE;

EID: 0024247067     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.168.5.1621     Document Type: Article

References (55)

1. Van Wauwe, J. P, J. R. DeMey, andJ. G. Goossens. 1980. OKT3: a monoclonal antihuman T lymphocyte antibody with potent mitogenic properties. J Immunol 124:2708.
2. Meuer, S. C., J. C. Hodgdon, R. E. Hussey, J. P Protentis, S. F. Schlossman, and E. L. Reinherz. 1983. Antigen-like effects of monoclonal antibodies directed at receptors on human T cell clones. J Exp. Med. 158:988.
3. Meuer, S. C., R. E. Hussey, M. Febbi, D. Fox, O. Acuto, K. A. Fitzgerald, J. C. Hodgdon, J. P Protentis, S. F Schlossman, and E. L. Reinherz. 1984. An alternative pathway of T-cell activation: a functional role for the 50 Kd Tll sheep erythrocyte receptor protein. Cell. 36:897.
4. Hara, T., S. M. Fu, and J. A. Hansen. 1985. Human T cell activation. II. A new activation pathway used by a major T cell population via a disulfide-bonded dimer of a 44 Kilodalton polypeptide (9.3 antigen). J Exp. Med. 161:1513.
5. Carrel, S., P Isler, S. Salvi, L. Giuffre, G. Pantaleo, J. -P. Mach, and J. -C. Cerottini. 1987. Identification ofa novel 45-KDa cell surface molecule involved in activation of the human Jurkat T cell line. Eur. J Immunol 17:1395.
6. Carrel, S., S. Salvi, L. Giuffre, P Isler, andJ. -C. Cerottini. 1987. A novel 90-KDa polypeptide (Tp90) possibly involved in an antigen-independent pathway ofT cell activation. Eur. J Immunol. 17:835.
7. Fleischer, B. 1987. A novel pathway ofhuman T cell activation via a 103 Kd T cell activation antigen. J Immunol. 138:1346.
8. Truneh, A., F. Albert, P Goldstein, and A. -M. Schmitt Verhulst. 1985. Early steps of lymphocyte activation bypassed by synergy between calcium ionophores and phorbol ester. Nature (Loud.). 313:318.
9. Hara, T., and S. M. Fu. 1985. Human T cell activatio. I. Monocyte-independent activation a proliferation induced by AntiT3 monoclonal antibodies in the presence oftumor promotor 12-o-tetradecanoyl phorbol-13-acetate. J Exp. Med. 161:641.
10. Holter, W., O. Majdic, H. Stockinger, andW Knapp. 1985. Analysis of T cell activation with a non-mitogenic anti-CD3 antibody and the phorbol ester TPA. Clin. Exp. Immunol. 62:600.
11. + + levels. J Exp. Med. 163:654.
12. Moretta, A., G. Pantaleo, M. López-Botet, and L. Moretta. 1985. Involvement of T44 molecules in an antigen-independent pathway ofT cell activation. Analysis ofthe correlation to the T cell antigen receptor complex. J. Exp. Med. 162:823.
13. Cotner, T., J. M. Williams, L. Christenson, H. M. Shapiro, T. B. Strom, and J. L. Strominger. 1983. Simultaneous flow cytometric analysis of human T cell activation antigen expression and DNA content. J. Exp. Med. 157:461.
14. Leonard, W. J., J. M. Depper, T. Uchiyama, K. A. Smith, T A. Waldmann, and W. C. Greene. 1982. A monoclonal antibody appears to recognize the receptor for human T cell growth factor ; partial characterization of the receptor. Nature (Land.). 300:267.
15. Trowbridge, I. S., and M. B. Omary. 1981. Human cell surface glycoprotein related to cell proliferation is the receptor for transferrin. Proc. Natl. Acad. Sci. USA. 78:3039.
16. Helderman, J. H., and T. B. Strom. 1978. Specific insulin binding sites on T and B lymphocytes as a marker of cell activation. Nature (Land.). 274:62.
17. Haynes, B. F., M. E. Hemler, D. L. Mann, G. S. Eisenbarth, J. Shelhamer, H. S. Mostowski, C. A. Thomas, J. L. Strominger, and A. S. Fauci. 1981. Characterization of a monoclonal antibody (4F2) that binds to human monocytes and to a subset of activated lymphocytes. J. Immunol. 126:1409.
18. Hara, T, L. K. L. Jung, J. M. Bjorndahl, and S. M. Fu. 1986. Human T cell activation. III. Rapid induction of a phosphorylated 28KD/32KD disulfide-linked early activation antigen (EA 1) by 12-o-tetradecanoyl phorbol-13-acetate, mitogens and antigens. J. Exp. Med. 164:1988.
19. Ko, H., S. Fu, R. Winchester, D. Yu, and H. Kunkel. 1979. la determinants on stimulated human T lymphocytes: occurrence on mitogen- and antigen-activated Tcells. J. Exp. Med. 150:246.
20. Fleischer, B., D. J. Schendel, and D. V Steldern. 1986. Triggering of the lethal hit in human cytotoxic T lymphocytes: a functional role for a 103-KDa T cell-specific activation antigen. Eur. J. Immunol. 16:741.
21. 1, a novel 105 KD human T cell activation antigen defined by a monoclonal antibody. J. Immunol. 133:1250.
22. Burns, G. F, T Triglia, J. A. Werkmeister, C. G. Begley, and A. W. Boyd. 1985. TLiSAl, a human T lineage-specific activation antigen involved in the differentiation of cytotoxic T lymphocytes and anomalous killer cells from their precursors. J. Exp. Med. 161:1063.
23. Hercend, T., J. Ritz, S. F Schlossman, and E. L. Reinherz. 1981. Comparative expression ofT9, T10, and la antigens on activated human T cells subsets. Hum. Immunol. 3:247.
24. Hemler, M. E., J. G. Jacobson, M. B. Brenner, D. Mann, and J. L. Strominger. 1985. VLA-1: a T cell surface antigen which defines a novel late stage ofhuman T cell activation. Eur. J. Immunol. 15:502.
25. Lefrancois, L., andM. J. Bevan. 1985. Functional modifications ofcytotoxic T-lymphocyte T200 glycoprotein recognized by monoclonal antibodies. Nature (Land.). 314:449.
26. Mastro, A. M., and G. C. Mueller. 1974. Synergistic action of phorbol ester in mitogen activated bovine lymphocytes. Exp. Cell Res. 88:40.
27. + +-sensitive phospholid-dependent protein kinase. Proc. Mad. Acad. Sci. USA. 81:5748.
28. Schreiber, A. B., I. Lax, Y. Yarden, Z. Esshhar, and J. Schlessinger. 1981. Monoclonal antibodies against receptor for epidermal growth factor induce early and delayed effects of epidermal growth factor. Proc. Natl. Acad. Sci. USA. 78:7535.
29. Spits, H., H. Yssel, J. Leeuwenberg, andJ. E. De Vries. 1985. Antigen-specific cytotoxic T cell and antigen-specific proliferation T cell clones can be induced to cytolytic activity by monoclonal antibodies against T3. Eur. J. Immunol. 15:88.
30. Burns, G. F, A. W. Boyd, and P. B. Beverly. 1982. Two monoclonal anti-human T lymphocyte antibodies have similar biologic effects and recognize the same surface antigen. J. Immunol. 129:1451.
31. López-Botet, M., A. Moretta, J. Lowenthal, R. Accolla, G. Pantaleo, and L. Moretta. 1986. Characterization ofmonoclonal antibodies directed against the human interleukin-2 receptor. Inmunologia 5:46.
32. Pulido, R., M. Cebrian, A. Acevedo, M. O. de Landazuri, and F. Sanchez-Madrid. 1988. Comparative biochemical and tissue distribution study of four distinct CD45 antigen specificities. J. Immunol. 140:3851.
33. Sánchez-Madrid, E, A. M. Krensky, C. F. Ware, E. Robbins, J. L. Strominger, S. J. Burakoff, and T. A. Springer. 1982. Three distinct antigens associated with human T lymphocyte-mediated cytolysis: LFA-1, LFA-2, and LFA-3. Proc. Natl. Acad. Sci. USA. 79:7489.
34. Malissen, B., N. Rebai, A. Liabeuf, and C. Mawas. 1982. Human cytotoxic T cell structures associated with expression of cytolysis. I. Analysis at the clonal cell level of the cytolysis-inhibiting effect of 7 monoclonal antibodies. Eur. J. ImmunoL 12:739.
35. Sánchez-Madrid, F., M. L. Toribio, F. Gambón, and M. O. de Landázuri. 1985. Cell surface molecular changes on the activation of human thymocytes.f. ImmunoL 135:3938.
36. Sánchez-Madrid, F., M. O. de Landázuri, G. Morago, M. Cebrián, A. Acevedo, and C. Bernabeu. 1986. VLA-3: A novel polypeptide association within the VLA molecular complex: cell distribution and biochemical characterization. Eur. J. ImmunoL 16:1343.
37. Carrera, A. C., F. Sánchez-Madrid, M. López-Botet, C. Bernabeu, and M. O. de Landázuri. 1987. Involvement of the CD4 molecule in a post-activation event on T cell proliferation. Eur. J. ImmunoL 17:179.
38. Galfre, G., and C. Milstein. 1981. Preparation of monoclonal antibodies: strategies and procedures. Methods Enzymol. 73:3.
39. Sánchez-Madrid, F., P. Szklut, and T. A. Springer. 1983. Stabl e hamster-mouse hybridomas producing IgG and IgM hamster monoclonal antibodies of defined specificity. J. ImmunoL 130:309.
40. Fraker, P. J., andJ. C. Speck. 1978. Protein and cell membrane iodionations with a sparingly soluble chloroamide 1, 3, 4, 6 tetrachloro-3, 6-diphenyl glycoluril. Biochem. Biophys. Res. Commun. 80:849.
41. Sanchez-Madrid, F., D. Davignon, E. Martz, and T. A. Springer. 1982. Antigens involved in mouse cytolytic Tlymphocyte (CTL)-mediated killing: functional screening and topographic relationship. Cell. ImmunoL 73:1.
42. Gillis, S., M. N. Ferm, and K. A. Smith. 1978. T cell growth factor: Parameters ofproduction and quantitative microassay for activity. J. Immunol. 120:1109.
43. Reinherz, E. L., S. C. Meuer, K. A. Fitzgerald, R. E. Hussey, H. Levine, and S. F. Schlossman. 1982. Antigen recognition by human T lymphocytes is linked to surface expression of the T3 molecular complex. Cell. 30:735.
44. Cantrell, D. A., A. A. Davies, and M. J. Crumpton. 1985. Activator s of protein kinase C down-regulated and phosphorylate the T3/=cell antigen receptor complex ofhuman T lymphocytes. Proc. Natl. Acad. Sci. USA. 82:8158.
45. Hemler, M. E., F. Sánchez-Madrid, T. J. Flotte, A. M. Krensky, S. J. Burakoff, A. K. Bhan, T. A. Springer, andJ. L. Strominger. 1984. Glycoprotein s of 210.000 and 130.000 m. w. on activated T cells: cell distribution and antigenic relation to components on resting cells and T cell lines. J ImmunoL 132:3011.
46. Fox, R. I., M. Hueniken, S. Fong, S. Behar, I. Royston, S. K. Singhal, and L. Thompson. 1983. A novel cell surface antigen (T305) found in increased frequency on acute leukemia cells and in autoimmune disease states. J. ImmunoL 131:762.
47. Lazarovits, D. L, R. A. Moscicki, J. T. Kurnick, D. Camerini, A. K. Bhan, L. G. Baird, M. Erikson, and R. B. Colvin. 1984. Lymphocyte activation antigens. I. A monoclonal antibody, anti-Act I, defines a new late lymphocyte activation antigen. J. ImmunoL 133:1857.
48. Suciu-Foca, N., E. Reed, P. Rubinstein, W. MacKenzie, Ah-Kau Ng, and D. W. King. 1985. A late-differentiation antigen associated with the helper inducer function ofhuman T cells. Nature (Loud.). 318:465.
49. Cosulich, M. E., A. Rubartelli, A. Risso, F. Cozzolino, and A. Bargellesi. 1987. Functional characterization of an antigen involved in an early step of T-cell. activation. Proc. Natl. Acad. Sci. USA. 84:4205.
50. Miyawaki, T., A. Yachie, N. Uwadana, S. Ohzeki, T. Nagaoki, and N. Taniguchi. 1982. Functional significance ofthe Tac antigen expressed on activated human T lymphocytes:Tac antigen interacts with T cell growth factor in cellular proliferation. f. Immunol. 129:2474.
51. Mendelsohn, J., I. Trowbridge, and J. Castagnola. 1983. Inhibition of human lymphocyte proliferation by a monoclonal antibody to transferrin receptor. Blood. 62:821.
52. Trowbridge, I., and F. Lopez. 1982. Monoclonal antibody to transferrin receptor blocks transferrin binding and inhibits human tumor cell growth "in vitro". Proc. Natl. Acad. Sci. USA. 79:1175.
53. Gordon, J., M. Rowe, L. Walker, and G. Guy. 1986. Ligation of the CD23, p45 (Blast-2, EBVCS) antigen triggers the cell-cycle progression of activated B lymphocytes. Eur. J Immunol. 16:1075.
54. Swendeman, S. L., and D. A. Thorley-Lawson. 1987. The activation antigen Blast-2, when shed, is a BCGF for normal and transformed B-lymphocytes. In Leukocyte Typing III. A. J. McMichael, P. C. L. Beverley, S. Cobbold, M. J. Crumpton, W. Gilks, F. M. Gotch, N. Hogg, M. Horton, N. Ling, I. C. M. Maclennan, D. Y. Mason, C. Milstein, D. Spiegelhalter, and H. Waldmann, editors. Springer-Verlag, New York. 453.
55. 2+ ex-changer activity in cardiac skeletal muscle sarcolemmal vesicles by monoclonal antibody 44137. J. Biol. Chem. 261:92.